Several of our students, associates, and alumni have gone off to found their own companies, building on the knowledge and experience they gained during their time at the NanoDTC. A number of these have been strongly supported by seed funds and translational funding from Cambridge Enterprise and have benefitted from the University Enterprise Network more generally.
Some of the startups/spinouts include:
ConcR
Next-generation oncology drug development - Dr. Matthew Griffiths, c2013
DeepMirror
AI for drug discovery - Dr. Ryan Greenhalgh, c2017
CamIn
Innovation Consulting - Dr. Dishant Mahendru, c2010 and Dr. Dirk Mersch, c2010
Semarion
Tools for more efficient drug trials - Dr. Tarun Vemulkar, c2012 and Dr. Jeroen Verheyen, NanoDTC Associate 2014
Echion Technologies
Fast charging batteries - Jean de la Verpilliere, c2013 and Dr. Alex Groombridge, c2013
Illumion
Charge photometry to measure energy storage in operating batteries - Dr. Alice Merryweather, c2018
HexagonFab
Portable on-site biomolecule analysis - Dr. Philipp Braueninger, NanoDTC Associate 2016
Calyxia
Nano-formulations - Dr. Jamie Walters, NanoDTC Associate 2010
Nu Quantum
Quantum Technologies for Satellites - Dr. Carmen Palacios Berraquero, c2013
Simprints Technology
Biometrics for the developing world - Alexandra Grigore, c2012
Cortirio
Rapid diagnosis of traumatic brain injury - Dr. Patrick Beldon, c2009
Sparxell
Sustainable pigments and glitter - Dr. Benjamin Droguet, NanoDTC Associate 2021